Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1995 Sep;101(3):449–452. doi: 10.1111/j.1365-2249.1995.tb03133.x

B cells capable of spontaneous IgG secretion in cerebrospinal fluid from patients with multiple sclerosis: dependency on local IL-6 production.

L Perez 1, J C Alvarez-Cermeño 1, C Rodriguez 1, E Roldán 1, J A Brieva 1
PMCID: PMC1553234  PMID: 7664492

Abstract

Cerebrospinal fluid (CSF) from multiple sclerosis (MS) patients contains B cells capable of spontaneous IgG secretion in vitro. This study analyses the function and regulation of these cells. CSF cells obtained from nine MS patients actively produced IgG during 2-3 days in culture, and the activity decreased when CSF cells were cultured in serum-free medium. CSF cells from four controls did not secrete detectable IgG in vitro. Further experiments revealed that IL-6 played a role on MS CSF IgG-secreting cells, as can be deduced from the following findings: (i) the addition of exogenous IL-6, but not of other cytokines, to serum-free cultures restored missing CSF cell IgG secretion (ii) the inclusion of anti-IL-6, but not of control, blocking MoAb reduced IgG secretion by CSF cells in fetal calf serum (FCS)-containing cultures; and (iii) CSF cells were capable of active IL-6 production in the presence of FCS. These results suggest that endogenous IL-6 production by MS CSF cells seems to be responsible for inducing CSF IgG-secreting B cells to reach terminal differentiation.

Full text

PDF
449

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brieva J. A., Martin R. A., Martinez-Maza O., Kagan J., Merrill J., Saxon A., Van Damme J., Stevens R. H. Interleukin 6 is essential for antibody secretion by human in vivo antigen-induced lymphoblastoid B cells. Cell Immunol. 1990 Oct 15;130(2):303–310. doi: 10.1016/0008-8749(90)90273-t. [DOI] [PubMed] [Google Scholar]
  2. Brieva J. A., Roldán E., Rodríguez C., Navas G. Human tonsil, blood and bone marrow in vivo-induced B cells capable of spontaneous and high-rate immunoglobulin secretion in vitro: differences in the requirements for factors and for adherent and bone marrow stromal cells, as well as distinctive adhesion molecule expression. Eur J Immunol. 1994 Feb;24(2):362–366. doi: 10.1002/eji.1830240214. [DOI] [PubMed] [Google Scholar]
  3. Ffrench-Constant C. Pathogenesis of multiple sclerosis. Lancet. 1994 Jan 29;343(8892):271–275. doi: 10.1016/s0140-6736(94)91118-5. [DOI] [PubMed] [Google Scholar]
  4. Henriksson A., Kam-Hansen S., Forsberg P., Grandien M. Cerebrospinal fluid lymphocytes from patients with multiple sclerosis do not increase immunoglobulin or measles antibody production after stimulation with pokeweed mitogen. J Neuroimmunol. 1986 Mar;11(1):15–30. doi: 10.1016/0165-5728(86)90071-8. [DOI] [PubMed] [Google Scholar]
  5. Hirano T., Akira S., Taga T., Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today. 1990 Dec;11(12):443–449. doi: 10.1016/0167-5699(90)90173-7. [DOI] [PubMed] [Google Scholar]
  6. Kurtzke J. F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 Nov;33(11):1444–1452. doi: 10.1212/wnl.33.11.1444. [DOI] [PubMed] [Google Scholar]
  7. Olsson T., Baig S., Höjeberg B., Link H. Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis. Ann Neurol. 1990 Feb;27(2):132–136. doi: 10.1002/ana.410270207. [DOI] [PubMed] [Google Scholar]
  8. Rodríguez C., Roldán E., Navas G., Brieva J. A. Essential role of tumor necrosis factor-alpha in the differentiation of human tonsil in vivo induced B cells capable of spontaneous and high-rate immunoglobulin secretion. Eur J Immunol. 1993 May;23(5):1160–1164. doi: 10.1002/eji.1830230527. [DOI] [PubMed] [Google Scholar]
  9. Roldán E., Rodriguez C., Navas G., Parra C., Brieva J. A. Cytokine network regulating terminal maturation of human bone marrow B cells capable of spontaneous and high rate Ig secretion in vitro. J Immunol. 1992 Oct 1;149(7):2367–2371. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES